MENU
+Compare
ANNX
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$2.51
Change
-$0.04 (-1.57%)
Capitalization
275.38M

ANNX Annexon Forecast, Technical & Fundamental Analysis

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye... Show more

ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ANNX with price predictions
Jul 25, 2025

ANNX sees MACD Histogram crosses below signal line

ANNX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ANNX moved out of overbought territory on July 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where ANNX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on July 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANNX as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANNX broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANNX advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 156 cases where ANNX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.130) is normal, around the industry mean (18.028). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). ANNX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (278.844).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ANNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANNX is expected to report earnings to fall 2.65% to -36 cents per share on August 18

Annexon ANNX Stock Earnings Reports
Q2'25
Est.
$-0.36
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.23
The last earnings report on May 13 showed earnings per share of -37 cents, missing the estimate of -30 cents. With 765.03K shares outstanding, the current market capitalization sits at 275.38M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
71
Web
https://www.annexonbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YLLXF6.850.09
+1.33%
Yellow Cake Plc
TORM1.17N/A
N/A
TOR Minerals International, Inc.
MYTHY53.00N/A
N/A
METLEN ENERGY & METALS S A
PPERF0.28N/A
N/A
PT Bank Mandiri Persero TBK
BBKCF0.09N/A
-2.69%
BIGG Digital Assets Inc.

ANNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-1.57%
IDYA - ANNX
47%
Loosely correlated
-1.33%
OCUL - ANNX
47%
Loosely correlated
+2.43%
ZYME - ANNX
45%
Loosely correlated
-4.85%
ERAS - ANNX
44%
Loosely correlated
+1.75%
TRML - ANNX
43%
Loosely correlated
+5.44%
More